Glen Eagle Advisors, LLC Novavax Inc Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 13, 2024	SELL	$5.76 - $12.48 $345 - $748	-60 Closed	0 $0
Q1 2021 Aug 13, 2024	SELL	$112.98 - $319.93 $2,259 - $6,398	-20 Reduced 25.0%	60 $10.9 Million
Q4 2020 Aug 13, 2024	BUY	$78.74 - $139.5 $6,299 - $11,160	80 New	80 $8.92 Million
Q3 2020 Aug 13, 2024	SELL	$79.44 - $178.51 $1,588 - $3,570	-20 Reduced 20.0%	80 $8.67 Million
Q2 2020 Aug 13, 2024	BUY	$13.86 - $83.61 $1,386 - $8,361	100 New	100 $8.34 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $692M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.